• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, December 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

A third of type one diabetes is misdiagnosed in the over 30s

Bioengineer by Bioengineer
April 30, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

More than a third of people over the age of 30 who are initially diagnosed with type 2 diabetes actually have type 1, meaning they are not receiving the right treatment,

More than a third of people over the age of 30 who are initially diagnosed with type 2 diabetes actually have type 1, meaning they are not receiving the right treatment, new research has revealed.

The study, led by the University of Exeter, shows that 38% of patients with type 1 diabetes occurring after age 30 were initially treated as type 2 diabetes (without insulin). the team found that half of those misdiagnosed were still diagnosed as type 2 diabetes 13 years later.

Prime Minister Theresa May is a classic case of misdiagnosis in later life. She was initially misdiagnosed with type 2 diabetes and treated with lifestyle change and tablets which did not work, before being re-tested and identified as having type 1 diabetes.

Dr Angus Jones, of the University of Exeter Medical School, who led the research, said: “For people with type 1 diabetes, taking tablets and losing weight are not effective – they need insulin treatment. It is very difficult to diagnose type 1 diabetes in older adults, as most people of this age will have type 2, even if they are thin. Our research shows that if a person diagnosed as type 2 diabetes needs insulin treatment within three years of diabetes diagnosis, they have a high chance of missed type 1 diabetes.Therefore they need a blood test to confirm what type of diabetes they have, to ensure they receive the right monitoring, education and treatment.”

The research, funded by NIHR and the Wellcome Trust, is published in the journal Diabetologia. With support from the NIHR Exeter Clinical Research Facility, the team analysed 583 people who had insulin-treated diabetes that had been diagnosed after the age of 30. The characteristics of their disease were compared with other participants who still produced some insulin, as well as with 220 individuals with severe insulin deficiency that was diagnosed before the age of 30.

T1D is characterised by the rapid and severe loss of insulin production as the cells in the pancreas which produce the hormone are attacked and destroyed by the body’s own immune system. Individuals with the disease lose the ability to make their own insulin and therefore require regular doses of insulin to control their blood glucose, either in the form of injections or via a pump, and unlike many people with T2D, cannot manage their condition through diet, exercise and tablets alone. Because they have a very high risk of low blood glucose (hypoglycaemia) they usually learn to match their insulin to food (carbohydrate counting) and may use new technology such as insulin pumps and continuous glucose monitors. These treatments are not available to people diagnosed as Type 2 diabetes even if they progress to needing insulin injections, therefore the right diagnosis remains important even if a person is treated with insulin.

First author Dr Nick Thomas, of the University of Exeter Medical School, said: “While people with type 2 diabetes may eventually need insulin, their treatment and education is very different from type 1. If people with type 1 diabetes don’t receive insulin they can develop very high blood glucose, and may develop a life threatening condition called ketoacidosis. This means having the right diagnosis is vitally important even if insulin treatment has already been started. ”

###

The full paper is entitled: Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

Media Contact
Louise Vennells
[email protected]

Tags: DiabetesDiagnosticsMedicine/HealthMetabolism/Metabolic Diseases
Share14Tweet8Share2ShareShareShare2

Related Posts

Public Sentiment on COVID-19 Policy Effectiveness

December 2, 2025

Junior Nurses’ Views on Adverse Events and Causes

December 2, 2025

Sepsis in Burns: Insights Gained, Challenges Persist

December 2, 2025

COVID-19’s Impact on Pediatric Bloodstream Infection Surveillance

December 2, 2025
Please login to join discussion

POPULAR NEWS

  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    203 shares
    Share 81 Tweet 51
  • Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton

    120 shares
    Share 48 Tweet 30
  • Neurological Impacts of COVID and MIS-C in Children

    106 shares
    Share 42 Tweet 27
  • MoCK2 Kinase Shapes Mitochondrial Dynamics in Rice Fungal Pathogen

    67 shares
    Share 27 Tweet 17

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Public Sentiment on COVID-19 Policy Effectiveness

Flavonoid Changes in Coffea Arabica L. Peel During Ripening

Junior Nurses’ Views on Adverse Events and Causes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.